SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/6126C00B9CC1C8570913DC7B8AF74CC5758205C7FE7DC87EA6D32F403B12AFF9045841BCD3D44606796A77A178E1288F>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/6126C00B9CC1C8570913DC7B8AF74CC5758205C7FE7DC87EA6D32F403B12AFF9045841BCD3D44606796A77A178E1288F
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/6126C00B9CC1C8570913DC7B8AF74CC5758205C7FE7DC87EA6D32F403B12AFF9045841BCD3D44606796A77A178E1288F
http://www.w3.org/2000/01/rdf-schema#comment
"The simultaneous action of PDGF-B/PDGFRbeta and VEGF165b on the same type of receptor may explain the resistance to antiangiogenic therapy which depends on the degree of modulation of PDGFRbeta phosphorylation."
xsd:string
http://purl.uniprot.org/uniprot/#_6AAA7E739D08B62AD6C6B22EE7FB4CCB971841BD78C3A6B7DCA5598E7B3D38188BE724BCE3DF7F3F9DA629FA82BD934F
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/6126C00B9CC1C8570913DC7B8AF74CC5758205C7FE7DC87EA6D32F403B12AFF9045841BCD3D44606796A77A178E1288F
http://purl.uniprot.org/uniprot/P09619
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/6126C00B9CC1C8570913DC7B8AF74CC5758205C7FE7DC87EA6D32F403B12AFF9045841BCD3D44606796A77A178E1288F
http://purl.uniprot.org/uniprot/#_P09619-mappedCitation-27127135
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/6126C00B9CC1C8570913DC7B8AF74CC5758205C7FE7DC87EA6D32F403B12AFF9045841BCD3D44606796A77A178E1288F